Generex Biotechnology Corporation
GNBT · OTC
4/30/2021 | 1/31/2021 | 10/31/2020 | 7/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2 | $1 | $1 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $1 | $1 | $1 |
| Other Curr. Assets | $1 | $0 | $0 | $0 |
| Total Curr. Assets | $2 | $2 | $2 | $1 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $34 | $34 | $34 | $34 |
| Intangibles | $9 | $9 | $9 | $9 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $43 | $44 | $44 | $44 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $46 | $46 | $46 | $45 |
| Liabilities | – | – | – | – |
| Payables | $41 | $39 | $33 | $24 |
| Short-Term Debt | $9 | $10 | $10 | $11 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $7 | $3 | $0 | $0 |
| Other Curr. Liab. | $7 | $7 | $9 | $7 |
| Total Curr. Liab. | $64 | $60 | $52 | $41 |
| LT Debt | $1 | $1 | $0 | $0 |
| Deferred Rev, NC | -$2 | -$2 | -$2 | -$2 |
| Deferred Tax Liab, NC | $2 | $2 | $2 | $2 |
| Other NC Liab. | $29 | $44 | $29 | $15 |
| Total NC Liab. | $30 | $45 | $30 | $16 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $94 | $105 | $82 | $57 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$480 | -$489 | -$465 | -$452 |
| AOCI | $1 | $1 | $1 | $1 |
| Other Equity | $422 | $420 | $418 | $430 |
| Total Equity | -$56 | -$68 | -$45 | -$21 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $4 | $4 | $4 | $0 |
| Total Liab. & Tot. Equity | $38 | $37 | $37 | $36 |
| Net Debt | $8 | $10 | $10 | $11 |